MedTrace Logo

DNA Analysis of Tumor Tissue From Patients With Acute Myeloid Leukemia

NCT00897936 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 418

Last updated 2020-07-31

No results posted yet for this study

Summary

RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how well patients respond to treatment.

PURPOSE: This laboratory study is looking at tissue samples from patients with acute myeloid leukemia.

Conditions

Interventions

GENETIC

DNA methylation analysis

GENETIC

comparative genomic hybridization

GENETIC

fluorescence in situ hybridization

GENETIC

microarray analysis

GENETIC

polymerase chain reaction

OTHER

diagnostic laboratory biomarker analysis

OTHER

immunologic technique

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • ECOG-ACRIN Cancer Research Group

    lead NETWORK

Principal Investigators

  • Ari M. Melnick, MD · Albert Einstein College of Medicine

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-23
Primary Completion
2009-10-15
Completion
2009-10-15

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00897936 on ClinicalTrials.gov